Whole-Body MRI and Whole Body [123I]-I-mIBG Scintigraphy: a Comparison in Intermediate and High Risk Neuroblastoma and validation of SIOPEN Scoring System in WB-MRI
Purpose: To assess the agreement between 123I-metaiodobenzylguanidine or [123I]-I-mIBG

